Atossa Therapeutics ATOS
NASDAQ ATOS
$2.09 -0.05 (-2.22%)
As of: Nov 11, 2026 · 12:38 PM EST

Atossa Therapeutics (ATOS) Other non-cash items (2009 - 2017)

Updated

Analysis

Atossa Therapeutics (ATOS) Other non-cash items (2009 - 2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Atossa Therapeutics 21.38 Mn -98.31 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 192,817.00
Sep 30, 2017 -64,517.00
Jun 30, 2017 345,264.00
Sep 30, 2015 625,499.00
Jun 30, 2015 344,212.00
Mar 31, 2015 218,482.00
Dec 31, 2014 128,418.00
Sep 30, 2014 16,111.00
Jun 30, 2014 36,899.00
Mar 31, 2014 27,860.00
Dec 31, 2011 0.34
Apr 30, 2009 382,721.00
API Access

Atossa Therapeutics Other non-cash items API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-cash-items&ticker=ATOS&period=max&api_key=YOUR_API_KEY